AU2003256280A1 - Methods of delivering gene therapy agents - Google Patents

Methods of delivering gene therapy agents

Info

Publication number
AU2003256280A1
AU2003256280A1 AU2003256280A AU2003256280A AU2003256280A1 AU 2003256280 A1 AU2003256280 A1 AU 2003256280A1 AU 2003256280 A AU2003256280 A AU 2003256280A AU 2003256280 A AU2003256280 A AU 2003256280A AU 2003256280 A1 AU2003256280 A1 AU 2003256280A1
Authority
AU
Australia
Prior art keywords
methods
gene therapy
therapy agents
delivering gene
delivering
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003256280A
Inventor
Kevin M. Baskin
Simon J. Eastman
Ronald K. Scheule
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genzyme Corp
Original Assignee
Genzyme Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genzyme Corp filed Critical Genzyme Corp
Publication of AU2003256280A1 publication Critical patent/AU2003256280A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0083—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the administration regime

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2003256280A 2002-06-24 2003-06-24 Methods of delivering gene therapy agents Abandoned AU2003256280A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39044402P 2002-06-24 2002-06-24
US60/390,444 2002-06-24
PCT/US2003/019639 WO2004001049A1 (en) 2002-06-24 2003-06-24 Methods of delivering gene therapy agents

Publications (1)

Publication Number Publication Date
AU2003256280A1 true AU2003256280A1 (en) 2004-01-06

Family

ID=30000557

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003256280A Abandoned AU2003256280A1 (en) 2002-06-24 2003-06-24 Methods of delivering gene therapy agents

Country Status (4)

Country Link
EP (1) EP1532255A1 (en)
JP (1) JP2006501177A (en)
AU (1) AU2003256280A1 (en)
WO (1) WO2004001049A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008521575A (en) * 2004-12-01 2008-06-26 ジェンザイム・コーポレイション Delivery method of genetic material targeting the liver
CN102725400A (en) * 2009-06-29 2012-10-10 麻省理工学院 Methods of producing humanized non-human mammals
JP5922864B2 (en) * 2010-06-15 2016-05-24 国立大学法人 新潟大学 Intracellular drug delivery system and intracellular drug delivery method based on time-intravascular pressure control
WO2012056756A1 (en) 2010-10-25 2012-05-03 学校法人立命館 Method for operating a device for delivering a substance to be introduced, and method for delivering a substance to be introduced
SG10201604810UA (en) * 2012-02-07 2016-08-30 Global Bio Therapeutics Inc Compartmentalized method of nucleic acid delivery and compositions and uses thereof
CA2874316A1 (en) 2012-05-03 2013-11-07 Indiana University Research And Technology Corporation Hydrodynamic methods for delivering fluids to kidney tissues and related materials and methods
EP3039138A4 (en) * 2013-08-30 2017-04-26 Indiana University Research and Technology Corporation Hydrodynamic method and apparatus for delivering fluids to kidney tissues
US20210370037A1 (en) * 2018-04-27 2021-12-02 Seattle Children's Hospital D/B/A Seattle Children's Research Institute Ultrasound-mediated gene and drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6416510B1 (en) * 1997-03-13 2002-07-09 Biocardia, Inc. Drug delivery catheters that attach to tissue and methods for their use
US6290689B1 (en) * 1999-10-22 2001-09-18 Corazón Technologies, Inc. Catheter devices and methods for their use in the treatment of calcified vascular occlusions
US6135976A (en) * 1998-09-25 2000-10-24 Ekos Corporation Method, device and kit for performing gene therapy

Also Published As

Publication number Publication date
WO2004001049A1 (en) 2003-12-31
EP1532255A1 (en) 2005-05-25
JP2006501177A (en) 2006-01-12

Similar Documents

Publication Publication Date Title
AU2003261251A1 (en) Methods of delivering therapeutic agents
AU2003291354A1 (en) Methods and compostions for therapeutic use of rna interference
AU2002322719A1 (en) Delivery of therapeutic capable agents
AU2003210497A1 (en) Gene delivery system and methods of use
AU2002332020A1 (en) Compositions for oral gene therapy and methods of using same
AU2003261100A1 (en) Devices delivering therapeutic agents and methods regarding the same
AU2003228436A1 (en) Method and apparatus for delivery of therapeutic agents
AU2002334969A1 (en) Use of stat-6 inhibitors as therapeutic agents
AU2003297621A1 (en) Medical devices for delivery of therapeutic agents
AU2003209086A1 (en) Oligonucleotide analogues and methods of use for modulating gene expression
AU2003222067A1 (en) System for delivery of therapeutic substances
AU2003209226A1 (en) Adiponectin gene therapy
AU2003211103A1 (en) Intracellular delivery of therapeutic agents
EP1490074A4 (en) Mixed- cell gene therapy
AU2003287254A1 (en) Inhibition of gene expression using rna interfering agents
AU2001245987A1 (en) Compositions and methods for gene therapy
AU2003277910A1 (en) Ocular gene therapy
AU2003299864A1 (en) Sirna compounds and methods for the downregulation of gene expression
AUPS160602A0 (en) Therapeutic method
AU2003293099A1 (en) Treatment of dna damage related disorders
AU2003230566A1 (en) Therapeutic regulation of deoxyribonuclease-1-like-3 activity
AU2003256280A1 (en) Methods of delivering gene therapy agents
GB0327384D0 (en) Gene therapy
AU2003230004A1 (en) Methods of therapy for inducing tolerance
AU2003218721A1 (en) Use of 8-prenylflavanones for anti-angiogenesis therapy and for fibrinolytic therapy

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase